Asset Manager

Updated:

Sonde Health

Sonde Health is a health technology company founded in 2015 in Boston, Massachusetts. It develops a vocal biomarker platform analyzing voice data for mental,...

Sonde Health

Sonde Health is a health technology company founded in 2015 in Boston, Massachusetts. It develops a vocal biomarker platform analyzing voice data for mental, cognitive, and respiratory health information. The company works with organizations to implement early detection and monitoring of health conditions.

General information

Firm type

Asset Manager

Location

Region

North America

Country

United States

City

Boston

Corporate office

Boston, MA, United States

Sector focus

Digital HealthAI/MLHealthcare Services

Frequently asked questions

Who leads investment decisions at Sonde Health?

Sonde Health is led by CEO David Liu, who oversees the company's strategic direction. The firm has not disclosed a separate CIO or investment committee given its focus on product development rather than capital management.

How does Sonde Health generate revenue?

Sonde Health licenses its voice biomarker software development kit to healthcare organizations, insurers, and telehealth platforms. It does not sell a consumer app or charge patients directly.

What conditions can Sonde Health's technology detect?

The platform analyzes vocal biomarkers to screen for respiratory conditions like COPD and asthma, as well as mental health conditions such as depression and anxiety. It has been validated in clinical studies with partners like Boston Children's Hospital (per public record).

Is Sonde Health a venture-backed startup or a family office?

Sonde Health is a privately held technology company, not a family office or asset manager. Its funding and ownership structure have not been publicly disclosed.

How does Sonde Health differentiate from other vocal biomarker startups?

Sonde Health has built a proprietary database of millions of labeled voice samples across multiple languages and populations, which it uses to train its AI models. The firm licenses its SDK rather than building consumer products, positioning it as infrastructure for healthcare providers.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Boston Asset Manager profiles